These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33244143)

  • 1. Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome.
    Pandolfi L; Fusco R; Frangipane V; D'Amico R; Giustra M; Bozzini S; Morosini M; D'Amato M; Cova E; Ferrario G; Morbini P; Colombo M; Prosperi D; Viglio S; Piloni D; Di Paola R; Cuzzocrea S; Meloni F
    Sci Rep; 2020 Nov; 10(1):20726. PubMed ID: 33244143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis.
    Codullo V; Cova E; Pandolfi L; Breda S; Morosini M; Frangipane V; Malatesta M; Calderan L; Cagnone M; Pacini C; Cavagna L; Recalde H; Distler JHW; Giustra M; Prosperi D; Colombo M; Meloni F; Montecucco C
    J Control Release; 2019 Sep; 310():198-208. PubMed ID: 31430501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents.
    Cova E; Inghilleri S; Pandolfi L; Morosini M; Magni S; Colombo M; Piloni D; Finetti C; Ceccarelli G; Benedetti L; Cusella MG; Agozzino M; Corsi F; Allevi R; Mrakic-Sposta S; Moretti S; De Gregori S; Prosperi D; Meloni F
    Nanotoxicology; 2017 May; 11(4):534-545. PubMed ID: 28415888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin prevents bronchiolitis obliterans through increasing infiltration of regulatory B cells in a murine tracheal transplantation model.
    Zhao Y; Gillen JR; Meher AK; Burns JA; Kron IL; Lau CL
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):487-96.e3. PubMed ID: 26481278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis of the Tracheal Epithelium Can Increase the Number of Recipient Bone Marrow-Derived Myofibroblasts in Allografts and Exacerbate Obliterative Bronchiolitis After Tracheal Transplantation in Mice.
    Wang C; Xia T; Jiang K; Qiao X; Zhang X; Li J; Wang J; Nie J
    Transplantation; 2016 Sep; 100(9):1880-8. PubMed ID: 27163540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib ameliorates bronchiolitis obliterans via inhibition of fibrocyte migration and differentiation.
    Watanabe S; Kasahara K; Waseda Y; Takato H; Nishikawa S; Yoneda T; Hara J; Sone T; Abo M; Kimura H; Nakao S
    J Heart Lung Transplant; 2017 Feb; 36(2):138-147. PubMed ID: 27388852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model.
    Zhao Y; Gillen JR; Harris DA; Kron IL; Murphy MP; Lau CL
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1668-1677.e5. PubMed ID: 24199758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK506 combined with GM6001 prevents tracheal obliteration in a mouse model of heterotopic tracheal transplantation.
    Li Y; Shu P; Tang L; Yang X; Fan J; Zhang X
    Transpl Immunol; 2019 Dec; 57():101244. PubMed ID: 31526865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of transforming growth factor-beta1/Smad3 signaling in bronchiolitis obliterans following lung transplantation].
    Liu HX; Li Y; Zhao CH; Liu Y; Zhang QG; Cong W; Lan XG; Xu S; Han LB; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(29):2069-73. PubMed ID: 17925182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation.
    Xu Z; Ramachandran S; Gunasekaran M; Zhou F; Trulock E; Kreisel D; Hachem R; Mohanakumar T
    J Heart Lung Transplant; 2015 Sep; 34(9):1154-62. PubMed ID: 25979625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potent anti-angiogenic factor, vasohibin-1, ameliorates experimental bronchiolitis obliterans.
    Watanabe T; Okada Y; Hoshikawa Y; Eba S; Notsuda H; Watanabe Y; Ohishi H; Sato Y; Kondo T
    Transplant Proc; 2012 May; 44(4):1155-7. PubMed ID: 22564651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated systemic administration of adipose tissue-derived mesenchymal stem cells prevents tracheal obliteration in a murine model of bronchiolitis obliterans.
    Lorenzi W; Gonçalves FDC; Schneider N; Silva ÉF; Visioli F; Paz AH; Saueressig MG
    Biotechnol Lett; 2017 Aug; 39(8):1269-1277. PubMed ID: 28528427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The macrolide clarithromycin inhibits experimental post-transplant bronchiolitis obliterans.
    Remund K; Rechsteiner T; Guo Z; Rentsch K; Boehler A
    Exp Lung Res; 2009 Dec; 35(10):830-40. PubMed ID: 19995277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PG490-88, a derivative of triptolide, attenuates obliterative airway disease in a mouse heterotopic tracheal allograft model.
    Leonard CT; Soccal PM; Berry GJ; Doyle RL; Theodore J; Duncan SR; Rosen GD
    J Heart Lung Transplant; 2002 Dec; 21(12):1314-8. PubMed ID: 12490278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis.
    Fan K; Qiao XW; Nie J; Yuan L; Guo HZ; Zheng ZK; Li JS; Wang JJ; Jiang K
    Transpl Immunol; 2013 Jun; 28(4):170-5. PubMed ID: 23619376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group.
    Elssner A; Jaumann F; Dobmann S; Behr J; Schwaiblmair M; Reichenspurner H; Fürst H; Briegel J; Vogelmeier C
    Transplantation; 2000 Jul; 70(2):362-7. PubMed ID: 10933164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome.
    Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Berlin A; Ross DJ; Kunkel SL; Charo IF; Strieter RM
    J Clin Invest; 2001 Aug; 108(4):547-56. PubMed ID: 11518728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR3 and its ligands in a murine model of obliterative bronchiolitis: regulation and function.
    Medoff BD; Wain JC; Seung E; Jackobek R; Means TK; Ginns LC; Farber JM; Luster AD
    J Immunol; 2006 Jun; 176(11):7087-95. PubMed ID: 16709871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
    Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction.
    Cova E; Colombo M; Inghilleri S; Morosini M; Miserere S; Peñaranda-Avila J; Santini B; Piloni D; Magni S; Gramatica F; Prosperi D; Meloni F
    Nanomedicine (Lond); 2015 Jan; 10(1):9-23. PubMed ID: 24559038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.